NIH will fund genomic variation research endeavors

By The Science Advisory Board staff writers

September 10, 2021 -- The National Institutes of Health (NIH) is providing $185 million over five years to the Impact of Genomic Variation on Function (IGVF) Consortium.

The funding was initiated and funded by the NIH's National Human Genome Research Institute (NHGRI), which will fund 25 awards across 30 U.S. research sites. Consortium investigators will work to understand how genomic variation alters human genome function and how such variation influences human health and disease.

The goal of IGVF Consortium is to advance understanding of how the human genome functions.
The goal of IGVF Consortium is to advance understanding of how the human genome functions. Image courtesy of Harry Wedel (NHGRI).

The consortium will develop a catalog of the results and approaches used in their studies, the NIH said. Consortium researchers will also develop computational modeling approaches to predict the impact of variants on genome function. All information generated will be made freely available to the research community through a web portal to assist with future research projects.

Synchron lands NIH grant for brain computer interface trial
Synchron has been awarded a $10 million grant by the U.S. National Institutes of Health (NIH) to study its Synchron motor neuroprosthesis in a new clinical...
NIH initiative tackles structural racism in biomedical research
A new framework to tackle structural racism was introduced by the U.S. National Institutes of Health (NIH) in a commentary published in the journal Cell...
NIH grants Vaxess $2.9M to develop vaccine patch
Vaxess Technologies announced it has received a $2.9 million grant from the National Institute of Allergy and Infectious Diseases, an agency of the...
NIH recommends outpatient use of Regeneron's COVID-19 antibody cocktail
Regeneron Pharmaceuticals said the U.S. National Institutes of Health (NIH) strongly recommends its Regen-CoV as an outpatient treatment for COVID-19...
NIH details progress of SCGE consortium
The U.S. National Institutes of Health (NIH) Somatic Cell Genome Editing (SCGE) consortium has provided a detailed update, published in Nature...

Copyright © 2021 scienceboard.net


Conferences
Bio-IT World Conference and Expo
September 20-22
Boston, Massachusetts United States
BioProcess International
September 20-23
Boston, Massachusetts United States
Cell and Gene Therapy Manufacturing and Commercialization
September 20-23
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter